financetom
Business
financetom
/
Business
/
Microvast Swings to Q2 Adjusted Earnings, Revenue Rises; Shares Drop After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Microvast Swings to Q2 Adjusted Earnings, Revenue Rises; Shares Drop After Hours
Aug 11, 2025 3:10 PM

05:35 PM EDT, 08/11/2025 (MT Newswires) -- Microvast ( MVST ) reported a Q2 non-GAAP net income late Monday of $0.05 per diluted share, compared with a loss of $0.28 per share a year earlier.

A single analyst polled by FactSet expected $0.02.

Revenue for the quarter ended June 30 rose to $91.3 million, from $83.7 million a year earlier.

Two analysts surveyed by FactSet expected $107.7 million.

The company reiterated its 2025 revenue guidance of $450 million to $475 million.

Two analysts surveyed by FactSet expect $472.7 million.

Shares of Microvast ( MVST ) were down more than 6% in after-hours activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Tesla's China-Made EV Sales Drop 11.5% in March
Market Chatter: Tesla's China-Made EV Sales Drop 11.5% in March
Apr 2, 2025
07:45 AM EDT, 04/02/2025 (MT Newswires) -- Tesla (TSLA) sold 78,828 China-made electric vehicles in March, down 11.5% from a year ago, Reuters reported Wednesday, citing data from the China Passenger Car Association. However, deliveries of the China-made Model 3 and Model Y cars during the month increased 156.9% from February, the report said. The company delivered 172,754 China-made cars...
Nurix Therapeutics Signs Exclusive Licensing Deal With Sanofi for Autoimmune Disease Program
Nurix Therapeutics Signs Exclusive Licensing Deal With Sanofi for Autoimmune Disease Program
Apr 2, 2025
07:46 AM EDT, 04/02/2025 (MT Newswires) -- Nurix Therapeutics ( NRIX ) said Wednesday that Sanofi ( SNY ) has exclusively licensed an undisclosed Nurix program targeting a previously undruggable transcription factor for autoimmune diseases. The company said the target is a key regulator of inflammation and is separate from its earlier disclosed STAT6 degrader program. Under the collaboration, Nurix...
BlackBerry Reports Higher Q4 Adjusted Net Income That Beats Forecasts
BlackBerry Reports Higher Q4 Adjusted Net Income That Beats Forecasts
Apr 2, 2025
07:48 AM EDT, 04/02/2025 (MT Newswires) -- BlackBerry (BB.TO) on Wednesday reported higher fourth-quarter adjusted profit that beat forecasts. The adjusted net income for the three months ending February 28, climbed to US$17.7 million, or US$0.03 per share, from US$16.4 million, or US$0.03 per share in the prior year period. The result beat analysts' expectations of US$ nil per share,...
Rockwell Automation Collaborates With Amazon's AWS for Cloud-Enabled Manufacturing
Rockwell Automation Collaborates With Amazon's AWS for Cloud-Enabled Manufacturing
Apr 2, 2025
07:44 AM EDT, 04/02/2025 (MT Newswires) -- Rockwell Automation ( ROK ) said Wednesday that it is collaborating with Amazon's ( AMZN ) cloud computing unit AWS to accelerate the digitalization of the manufacturing industry using cloud-enabled solutions. The collaboration aims to help manufacturers optimize asset performance, increase operational visibility, and generate actionable insights from raw data by combining Rockwell's...
Copyright 2023-2026 - www.financetom.com All Rights Reserved